Corticosteroids or ACTH for acute exacerbations in multiple sclerosis
Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
Published Online: 23 OCT 2000
Assessed as up-to-date: 30 OCT 2002
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Citterio A, La Mantia L, Ciucci G, Candelise L, Brusaferri F, Midgard R, Filippini G. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD001331. DOI: 10.1002/14651858.CD001331.
- Publication Status: Unchanged
- Published Online: 23 OCT 2000
This article has been cited by:
- 1Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial, Iranian Red Crescent Medical Journal, 2015, 17, 10, , ,
- 2Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial, The Lancet, 2015, 386, 9997, 974, , , , , , , , , , ,
- 3Treatment of Multiple Sclerosis Exacerbations, Neurologic Clinics, 2011, 29, 2, 389, ,
- 4Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: Long-term protective effects and enhanced efficacy of methylprednisolone formulations, Experimental Neurology, 2008, 211, 2, 397, , , , , , , ,
- 5Journal of the Neurological Sciences, 2005, 234, 1-2, 117, ,